Fingolimod Hydrochloride is Used for treating autoimmune diseases and multiple sclerosis, including relapsing-remitting and pediatric patients. It was first introduced by Novartis Pharmaceuticals Corp in its drug Gilenya on Sep 21, 2010. 18 different companies have introduced drugs containing Fingolimod Hydrochloride.

Fingolimod Hydrochloride Patents

Given below is the list of patents protecting Fingolimod Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Gilenya	US9592208 (Pediatric)	Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol	Sep 30, 2032	Novartis
Gilenya	US9592208	Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol	Mar 30, 2032	Novartis
Gilenya	US10543179	Dosage regimen of an S1P receptor modulator	Dec 25, 2027	Novartis
Gilenya	US9187405 (Pediatric)	S1P receptor modulators for treating relasping-remitting multiple sclerosis	Dec 25, 2027	Novartis
Gilenya	US9187405	S1P receptor modulators for treating relasping-remitting multiple sclerosis	Jun 25, 2027	Novartis
Gilenya	US8324283 (Pediatric)	Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol	Sep 29, 2026	Novartis
Gilenya	US8324283	Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol	Mar 29, 2026	Novartis
Gilenya	US5604229 (Pediatric)	2-amino-1,3-propanediol compound and immunosuppressant	Aug 18, 2019 (Expired)	Novartis
Gilenya	US5604229	2-amino-1,3-propanediol compound and immunosuppressant	Feb 18, 2019 (Expired)	Novartis
Gilenya	US6004565	Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties	Sep 23, 2017 (Expired)	Novartis
Gilenya	US5604229	2-amino-1,3-propanediol compound and immunosuppressant	Feb 18, 2014 (Expired)	Novartis

Add above patents to watchlist

Fingolimod Hydrochloride's Family Patents

Full family tree

Fingolimod Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Fingolimod Hydrochloride. The first generic version for Fingolimod Hydrochloride was by Biocon Ltd and was approved on Dec 4, 2019. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Feb 28, 2024.

Given below is the list of companies who have filed for Fingolimod Hydrochloride generic, along with the locations of their manufacturing plants worldwide.